Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Dalcetrapib decreases red blood cell sickling propensity in sickle cell disease
HTML
Details
Locations
Year:
2026
Type:
article
Source:
Clinical Hemorheology and Microcirculation
DOI:
10.1177/13860291261475024
Authors:
Claire Bordat,
Elie Nader,
Philippe Connes,
Philippe Joly,
Solene Poutrel,
Anne Perez,
Eric Niesor
show all 7
Institutions:
Laboratoire Interuniversitaire de Biologie de la Motricité,
Hospices Civils de Lyon
Language:
English
Topic:
Hemoglobinopathies and Related Disorders
Subfield:
Genetics (clinical)
Field:
Medicine
Domain:
Health Sciences
Keywords:
dalcetrapib,
voxelotor,
sickle cell disease,
red blood cell sickling,
erythrocyte deformability,
hemoglobin oxygen affinity,
hemoglobin S,
hypoxia,
red blood cell rheology
show all 9
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W7202291985
FWCI:
Cites:
43
Cited by:
Related to:
10